Lipid intervention in diabetes, metabolic syndrome and beyond

Int J Cardiol. 2018 Oct 1;268:200-201. doi: 10.1016/j.ijcard.2018.05.035.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids
  • Metabolic Syndrome*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Lipids